Therapix Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TRPXY and buy or sell other stocks, ETFs, and their options commission-free!

About TRPXY

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It operates through the Drug Development and Online Sales segments. 

CEO
Oz Adler, CPA
CEOOz Adler, CPA
Employees
Employees
Headquarters
Tel Aviv, Tel Aviv
HeadquartersTel Aviv, Tel Aviv
Founded
2004
Founded2004
Employees
Employees

TRPXY Key Statistics

Market cap
9.08M
Market cap9.08M
Price-Earnings ratio
-0.31
Price-Earnings ratio-0.31
Dividend yield
Dividend yield
Average volume
6.01K
Average volume6.01K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$12.25
52 Week high$12.25
52 Week low
$2.75
52 Week low$2.75

Stock Snapshot

The current Therapix Biosciences(TRPXY) stock price is $5.98, with a market capitalization of 9.08M. The stock trades at a price-to-earnings (P/E) ratio of -0.31.

On 2025-12-17, Therapix Biosciences(TRPXY) stock opened at —, reached a high of —, and a low of —.

The Therapix Biosciences(TRPXY)'s current trading volume is 0, compared to an average daily volume of 6.01K.

In the last year, Therapix Biosciences(TRPXY) shares hit a 52-week high of $12.25 and a 52-week low of $2.75.

In the last year, Therapix Biosciences(TRPXY) shares hit a 52-week high of $12.25 and a 52-week low of $2.75.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.